If you distribute medical devices internationally, understanding FDA 510(k) vs CE MDR is not optional — it determines which products you can sell in which markets, how long it takes to get there, and what legal responsibilities land on your desk. The U.S. and EU systems were built on different philosophies, and a device that's perfectly compliant in one market can be unsellable in the other.
This guide compares the two frameworks in plain terms: how approval pathways work, how device classes map, what technical documentation each side demands, and — most importantly for your bottom line — how to choose product lines that minimize duplicate regulatory work.
Regulations evolve, so always verify specifics against the latest official FDA and EU guidance before making sourcing decisions.
The Core Difference in One Sentence
The FDA system is a centralized, premarket review system run by a single federal agency: most moderate-risk devices reach the U.S. market through the 510(k) pathway, where the manufacturer proves the device is "substantially equivalent" to one already legally sold.
The
EU MDR system is a decentralized conformity-assessment system: manufacturers demonstrate compliance with the Medical Device Regulation (EU 2017/745), usually through an independent
Notified Body, and then affix the CE mark — which opens the entire EU/EEA market.
Neither certificate substitutes for the other. Selling in both markets means satisfying both.
Side-by-Side Comparison

key differences between U.S. and EU medical device pathways.
Understanding the FDA Pathways: 510(k), De Novo, and PMA
When a supplier tells you their product "has FDA," your first question should be: which pathway?
-
510(k) Premarket Notification — the workhorse route for Class II devices (blood pressure monitors, nebulizers, many test kits). The manufacturer demonstrates substantial equivalence to a predicate. Typical review timelines run around 90 FDA review days, with total elapsed time often several months. A "510(k) cleared" device is not "FDA approved" — that wording distinction matters in your marketing, too.
-
De Novo — for novel low-to-moderate-risk devices with no suitable predicate. It creates a new device classification. Less common, longer, but increasingly used for innovative home diagnostics.
-
PMA (Premarket Approval) — the rigorous route for Class III high-risk devices, requiring valid scientific evidence including clinical data. Rarely relevant for the home-monitoring and consumable categories most importers handle.
-
Exempt devices — many Class I and some Class II devices are 510(k)-exempt, but "exempt" never means "unregulated": registration, listing, UDI, labeling, and quality system rules still apply.

a visual overview of three FDA premarket pathways.
Buyer takeaway:
ask for the 510(k) number (format: K followed by six digits) and look it up in the FDA's public
510(k) database. Confirm the cleared model, indications for use, and the clearance holder match what you're buying.
What Changed with MDR vs. the Old MDD
If you sourced EU-bound devices before 2021, do not assume old habits still work. The MDR tightened the system significantly:
-
Up-classification: many products that were self-declared Class I under the MDD — reusable surgical instruments, certain software, some substance-based products — now require Notified Body certification.
-
Stricter clinical evidence: clinical evaluation is mandatory for all classes, and equivalence claims against competitors' devices are far harder to make.
-
Economic operator obligations: the MDR formally defines the duties of manufacturers, Authorized Representatives, importers (Article 13), and distributors (Article 14). Importers must verify CE marking, labeling, UDI, and traceability — and can be liable if they place non-compliant devices on the market.
-
Notified Body bottleneck: MDR certification can take considerable time due to Notified Body capacity constraints.
However, certain devices certified under the previous MDD may remain eligible for extended transitional periods, potentially until December 2027 or December 2028, provided the applicable conditions are met. Importers should verify the certificate's status and transitional eligibility rather than assuming legacy certificates are automatically invalid.
-
Person Responsible for Regulatory Compliance (PRRC): manufacturers and Authorized Representatives must designate one.

reviewing documentation gaps during the transition from MDD to MDR.
Scenario example:
A distributor sourcing
home diagnostic test kits discovers that the products were previously marketed under the old In Vitro Diagnostic Medical Devices Directive (IVDD), not the MDD. Under the newer IVDR (EU 2017/746), many in vitro diagnostic products face stricter classification, performance evaluation, and Notified Body requirements.
Before placing new orders, the distributor must confirm whether the products have valid IVDR conformity documentation or qualify for applicable transitional provisions. Failing to check this early could disrupt the entire product line.
Important distinction: MDR vs. IVDR
The EU MDR (
Regulation (EU) 2017/745) generally covers medical devices such as blood pressure monitors, nebulizers, and pulse oximeters.
In contrast, the EU IVDR (
Regulation (EU) 2017/746) covers in vitro diagnostic devices used to examine human specimens, including many hemoglobin meters, cholesterol testing systems, and home diagnostic test kits.
Importers should identify the applicable regulation before checking CE documentation, device classifications, or Notified Body requirements.

a nebulizer and cholesterol meter illustrate the distinction between MDR and IVDR.
Same Product, Two Markets: What to Prepare Separately
Suppose you want to sell a fingertip pulse oximeter or a
hemoglobin meter in both the U.S. and Germany. Both products must satisfy applicable FDA requirements in the United States, but their EU regulatory pathways differ.
A medical-purpose pulse oximeter generally falls under the MDR, while a hemoglobin meter designed to examine blood samples generally falls under the IVDR. The following checklist highlights what importers should prepare separately.
For the U.S.:
-
Confirm FDA product classification and regulation number
-
Verify the manufacturer's 510(k) clearance covers the exact model and intended use
-
Manufacturer registered, device listed; foreign manufacturer has a U.S. Agent
-
UDI on label and package; GUDID data submitted
-
U.S.-compliant labeling and English IFU
For the EU:
-
Confirm whether the product falls under MDR (EU 2017/745) or IVDR (EU 2017/746), and determine its classification under the applicable regulation.
-
Verify the CE conformity documentation for the exact model, including a valid Notified Body certificate where third-party certification is required.
-
Confirm that an EU Authorized Representative is appointed where required.
-
Check applicable EUDAMED registration requirements. Since May 28, 2026, four modules have been mandatory for relevant users: Actor Registration, UDI/Device Registration, Notified Bodies & Certificates, and Market Surveillance. Transitional registration deadlines may apply to certain existing devices.
-
Ensure the importer information, labeling, and instructions for use meet the requirements of the destination EU member state.
-
Confirm appropriate post-market surveillance documentation, including PMCF under MDR or PMPF under IVDR where applicable, and periodic safety update reports where required.

separate documentation streams for the same device in two markets.
One product, two technical files, two labeling streams, two registration ecosystems.
This is exactly where a sourcing partner earns its keep: at MedAsia, we verify both certificate tracks with the FDA database and the relevant Notified Body before you commit to a purchase order, and we coordinate
OEM labeling so both versions run correctly on the same production line.
Request a Quote to discuss dual-market sourcing.
Product Selection Advice for Distributors and Private Label Buyers
Compliance work scales with the number of distinct certificates your catalog depends on. Practical rules of thumb:
-
Prioritize dual-certified product lines. Prioritize product lines with the necessary FDA clearance or other applicable U.S. marketing authorization and CE conformity documentation under MDR or IVDR, as appropriate. This can help distributors serve both markets without starting separate regulatory processes from scratch. Always verify the exact model, intended use, and scope of the supporting documentation.
-
Check certificate scope, not just existence. A certificate covering "models X1–X3" does not cover the X4 variant the factory wants to sell you. Model-by-model verification is non-negotiable.

matching packaging identifiers with the product specification checklist.
-
Prefer established, boring categories. Blood pressure monitors, nebulizers, and standard home test meters have well-trodden regulatory paths, abundant predicate devices, and many qualified factories — lower compliance risk and faster restocking than novel categories.
-
Beware "CE pending" promises. Under MDR, certification timelines are long and uncertain. A factory whose MDR certificate is "in progress" may deliver in six months or never. Contractually tie payment milestones to certificate issuance.
-
Map your own legal role. Decide upfront whether you import as a distributor (manufacturer holds all registrations) or private label as the legal manufacturer under MDR — the latter brings full manufacturer obligations, including the technical documentation and PRRC requirements.
Scenario example:
Option A: the factory remains the legal manufacturer and provides the required IVDR conformity documentation, including Notified Body certification where applicable. The importer distributes the product with the appropriate importer identification and labeling.
Option B: the importer markets the device under its own name or trademark and may assume manufacturer-level obligations under IVDR Article 16, unless the applicable conditions for an exception are met.
The unit price may be identical, but the regulatory responsibilities are not. Choose deliberately.
How to Verify Certificates Before You Buy
FDA: search the 510(k) database by K-number or applicant name; check establishment registration and device listing in the FDA registration & listing database.
CE/MDR/IVDR: Determine whether the device falls under MDR or IVDR. Where Notified Body certification is required, verify the certificate's validity, scope, covered models, and applicable regulation. Cross-check the Notified Body's designation and relevant certificate information through official EU resources, including EUDAMED where available.
Cross-check the basics: the legal manufacturer name and address on the certificate must match the factory actually producing your goods; the model list must include your SKU; dates must be current.

cross-checking supplier reports and documentation before ordering.
Doing this across multiple factories and product lines is time-consuming — especially across time zones and languages. That's the daily work of a sourcing partner.
Our team, trained as ISO 13485 internal auditors, audits factories, verifies certificates at the source, and keeps your documentation trail clean from quotation to shipment.
Request a Quote and we'll run the verification for your next product line.
Frequently Asked Questions
01. Is FDA 510(k) clearance the same as FDA approval?
No. 510(k) is a "clearance" based on substantial equivalence to a predicate device, used for most Class II devices. "FDA approval" technically refers to PMA, the rigorous pathway for high-risk Class III devices. Using "FDA approved" in marketing a 510(k)-cleared device is a common compliance error.
02. Does a CE mark under MDR let me sell in the United States?
No. CE marking and FDA clearance are completely independent systems. A CE-marked device still needs the appropriate FDA pathway — registration and listing for exempt devices, 510(k) clearance, De Novo, or PMA — before it can be legally marketed in the U.S., and vice versa for the EU.
03. How long does FDA 510(k) clearance take?
FDA's review target is around 90 review days, but total elapsed time — including preparation, testing, and any additional-information requests — commonly runs six to twelve months. MDR Notified Body certification frequently takes a year or more given current capacity constraints.
04. What is the biggest practical difference between MDR and the old MDD?
Scope and evidence. MDR up-classified many devices into Notified Body territory, made clinical evaluation mandatory for all classes, added formal importer and distributor obligations, and introduced EUDAMED registration. Many devices that were self-certified under MDD now require full third-party certification.
05. As an importer, what are my legal duties under the EU MDR?
Under MDR Article 13, importers must verify CE marking, EU Declaration of Conformity, labeling, UDI, and the manufacturer's Authorized Representative; ensure storage and transport conditions; keep traceability records; and report non-compliant devices. Private labeling under your own name can make you the legal manufacturer.
06. Should I choose products with both FDA and CE certification?
Generally yes. Dual-certified product lines let you serve both markets from one supplier relationship, spread compliance costs, and signal that the factory operates a mature quality system. Always verify both certificates independently and confirm the certified models match your SKUs.
Disclaimer: This article is for general informational purposes and does not constitute legal or regulatory advice. Regulatory requirements and transitional arrangements change; always confirm current rules with the FDA, your Notified Body or EU Authorized Representative, or a qualified regulatory consultant before making market-entry decisions.